|
業務類別
|
Biotechnology |
|
業務概覽
|
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries. |
| 公司地址
| 8 Moore Drive, Durham, NC, USA, 27713 |
| 電話號碼
| +1 877 495-0816 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.fortrea.com |
| 員工數量
| 14300 |
| Mr. Mark A. Morais |
Chief Operating Officer and President, Clinical Services |
美元 506.58K |
27/04/2026 |
| Ms. Jill McConnell |
Chief Financial Officer |
美元 506.58K |
27/04/2026 |
| Mr. Anshul Thakral |
Director, President and Chief Executive Officer |
美元 401.92K |
27/04/2026 |
| Mr. Robert A. Parks |
Chief Accounting Officer |
-- |
26/02/2026 |
|
|
| Ms. Erin L. Russell |
Independent Director |
27/04/2026 |
| Ms. A. Machelle Sanders |
Independent Director |
27/04/2026 |
| Mr. David R. Smith |
Independent Director |
27/04/2026 |
| Dr. Amrit Ray, M.B.A.,M.D. |
Independent Director |
27/04/2026 |
| Mr. William J. Sharbaugh |
Director |
27/04/2026 |
| Mr. Anshul Thakral |
Director, President and Chief Executive Officer |
27/04/2026 |
| Mr. Peter M. Neupert |
Chairman of the Board |
27/04/2026 |
| Mr. Edward A. Pesicka |
Independent Director |
27/04/2026 |
|
|
|
|
